Copyright
©The Author(s) 2020.
World J Gastroenterol. Mar 14, 2020; 26(10): 1005-1019
Published online Mar 14, 2020. doi: 10.3748/wjg.v26.i10.1005
Published online Mar 14, 2020. doi: 10.3748/wjg.v26.i10.1005
Figure 2 Basis of spleen tyrosine kinase activation.
In the resting state, spleen tyrosine kinase is auto-inhibited, because of the binding of interdomain A and interdomain B to the kinase domain. This auto-inhibited conformation can be activated by binding of the two spleen tyrosine kinase homology 2 domains to dually phosphorylated immune-receptor tyrosine-based activation motifs or by phosphorylation of linker tyrosine’s in interdomain A or B. SH2: Spleen tyrosine kinase homology 2; ITAM: Immune-receptor tyrosine-based activation motifs.
- Citation: Kurniawan DW, Storm G, Prakash J, Bansal R. Role of spleen tyrosine kinase in liver diseases. World J Gastroenterol 2020; 26(10): 1005-1019
- URL: https://www.wjgnet.com/1007-9327/full/v26/i10/1005.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i10.1005